Clinical Trial Update: Moxifloxacin vs. Polytrim for Conjunctivitis [Phase 4]

View source ↗

Summary

Phase 4 trial comparing moxifloxacin ophthalmic solution with Polytrim for conjunctivitis has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Conjunctivitis

Drugs mentioned

• Moxifloxacin ophthalmic solution (moxifloxacin)
• Polytrim (polymyxin B/trimethoprim) (polymyxin B/trimethoprim)

Snippet

Sponsor: University of Rochester | Conditions: Conjunctivitis | Phase 4 | Status: COMPLETED | Results posted: 2016-01-18